PRIFTIN

This brand name is authorized in Estonia, Hong Kong, Singapore, United States, South Africa

Active ingredients

The drug PRIFTIN contains one active pharmaceutical ingredient (API):

1 Rifapentine UNII XJM390A33U - RIFAPENTINE

Rifapentine, a cyclopentyl rifamycin, is an antimycobacterial agent. Rifapentine inhibits DNA-dependent RNA polymerase in susceptible strains of Mycobacterium tuberculosis but not in mammalian cells. At therapeutic levels, rifapentine exhibits bactericidal activity against both intracellular and extracellular M. tuberculosis organisms. Read about Rifapentine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
PRIFTIN Film-coated tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J04AB05	Rifapentine	J Antiinfectives for systemic use → J04 Antimycobacterials → J04A Drugs for treatment of tuberculosis → J04AB Antibiotics
Discover more medicines within J04AB05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1755457
Country: HK	Department of Health Drug Office	Identifier(s): 65512
Country: SG	Health Sciences Authority	Identifier(s): 15793P
Country: US	FDA, National Drug Code	Identifier(s): 0088-2100, 0088-2102, 50090-5063
Country: ZA	Health Products Regulatory Authority	Identifier(s): 51/20.2.3/1081